These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8697512)

  • 21. [Studies on the clinical significance of serum type III procollagen peptide levels as a tumor marker in patients with gynecologic tumors].
    Mori T; Itoh E
    Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2732-42. PubMed ID: 3249113
    [No Abstract]   [Full Text] [Related]  

  • 22. [The changes in collagen contents and its clinical significance in chronic obstructive pulmonary disease].
    Dong B; Zhou J; Wang Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):301-2, 319. PubMed ID: 8762485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of serum type-III procollagen aminopropeptide in hepatitis B virus-related liver diseases.
    Chang TT; Lin HC; Lee SD; Tsai YT; Lee FY; Jeng FS; Wu JC; Yeh PS; Lo KJ
    Scand J Gastroenterol; 1989 Jun; 24(5):533-8. PubMed ID: 2762752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes of serum elastase, alpha 1-antitrypsin, procollagen III peptide and malonaldehyde in smokers with and without chronic obstructive pulmonary diseases].
    Chen X; Cheng X; Li J; Zhang H; Hua Y; Xu X; Zhao Q; Li Q; Qin F; Yu L; Li Z; Li Y
    Zhonghua Nei Ke Za Zhi; 1999 Mar; 38(3):178-80. PubMed ID: 11798647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of serum procollagen-III-peptide in reflecting the therapeutic effects of calcium-channel blockers on hepatic fibrosis].
    Li DG; Lu HM; Li XH
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):453-6, 509. PubMed ID: 2086011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum type III procollagen peptide in tissue fibrosis].
    Maruyama K
    Rinsho Byori; 1985 Jan; 33(1):27-32. PubMed ID: 3990010
    [No Abstract]   [Full Text] [Related]  

  • 27. [Application of serum type III procollagen peptide level in the diagnosis of lung fibrosis developed during bleomycin treatment in cancer patients].
    Okazaki I; Miura K; Ohya S; Murakami M; Nagata N; Maruyama K; Kobayashi T; Okuno F; Oda S; Ito H
    Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2104-11. PubMed ID: 2419464
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum amino-terminal propeptide of type III procollagen levels in chronic pancreatitis.
    Navarro S; Valderrama R; Lopez JM; Gimenez A; Caballeria J; Pares A; Fernandez-Cruz L
    Pancreas; 1996 Mar; 12(2):153-8. PubMed ID: 8720662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseases.
    Collazos J; Díaz F
    Clin Chim Acta; 1994 Jun; 227(1-2):37-43. PubMed ID: 7955420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum type III procollagen peptide in asbestos workers: an early indicator of pulmonary fibrosis.
    Cavalleri A; Gobba F; Bacchella L; Luberto F; Ziccardi A
    Br J Ind Med; 1988 Dec; 45(12):818-23. PubMed ID: 3219307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procollagen type III amino terminal peptide (PIIIP) is associated with left ventricular diastolic dysfunction in obstructive sleep apnoea.
    Vautrin E; Pépin JL; Faure P; Barone-Rochette G; Tamisier R; Ormezzano O; Gauchez AS; Levy P; Baguet JP
    Int J Cardiol; 2011 Sep; 151(3):387-8. PubMed ID: 21783267
    [No Abstract]   [Full Text] [Related]  

  • 32. Markers of tissue response to thyroid hormones in patients with hyperthyroidism or hypothyroidism.
    Kucharz EJ; Marcisz C; Jonderko G; Jurecka-Tuleja B; Gołab T; Gina AR
    Rom J Intern Med; 1997; 35(1-4):71-5. PubMed ID: 9562655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis.
    Trivedi P; Cheeseman P; Portmann B; Hegarty J; Mowat AP
    Eur J Clin Invest; 1985 Apr; 15(2):69-74. PubMed ID: 3922770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
    Simojoki M; Santala M; Risteli J; Risteli L; Kauppila A
    Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentration of the aminoterminal procollagen type III peptide in the rat reflects early formation of connective tissue in experimental liver cirrhosis.
    Schuppan D; Dumont JM; Kim KY; Hennings G; Hahn EG
    J Hepatol; 1986; 3(1):27-37. PubMed ID: 3745883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum procollagen-III-peptide level correlates with disease activity in myelofibrosis with myeloid metaplasia.
    Barosi G; Costa A; Liberato LN; Polino G; Spriano P; Magrini U
    Br J Haematol; 1989 May; 72(1):16-20. PubMed ID: 2736239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolyl hydroxylase and procollagen III peptide levels in the sera from patients with collagen diseases and psoriasis.
    Sasaki T; Nakajima H
    J Dermatol; 1989 Jun; 16(3):207-11. PubMed ID: 2551942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of bone-specific alkaline phosphatase and procollagen type I carboxyterminal peptide in vitamin D deficiency.
    Nawawi H; Girgis SI
    Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():124-30. PubMed ID: 12755282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.
    Timonen P; Magga J; Risteli J; Punnonen K; Vanninen E; Turpeinen A; Tuomainen P; Kuusisto J; Vuolteenaho O; Peuhkurinen K
    Int J Cardiol; 2008 Mar; 124(3):293-300. PubMed ID: 17442428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
    Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.